Medical Research
(H90)
BIOSTASIS TECHNOLOGIES INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$560K
Total Revenue
$537K
Total Expenses
$34K
Net Assets
4
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
76.8%
Fundraising Efficiency
0.0%
Operating Reserve
0.76x
Liability-to-Asset
80.2%
Revenue Diversification
100.0%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $560K | $537K | $34K | 76.8% | 4 |
| 2022 | $169K | $158K | N/A | — | 3 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.